MedTrace Logo

Specifying Interventions From the Sickle Cell Disease Implementation Consortium (SCDIC)

NCT03380351 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 17

Last updated 2024-05-08

No results posted yet for this study

Summary

The goal of this study is to specify the interventions, implementation strategies and control conditions from the Sickle Cell Disease Implementation Consortium (SCDIC) using a mixed-methods approach to study site materials and conduct semi-structured qualitative interviews with site representatives (N=3 per site). We focused on the Emergency Department Working Group from the SCDIC working groups.

Conditions

  • Anemia, Sickle Cell

Interventions

BEHAVIORAL

SCDIC interventions

The research team will characterize the intervention components and their implementation strategies.

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • Washington University School of Medicine

    lead OTHER

Principal Investigators

  • Ana Baumann, PhD · Washington University School of Medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-08-26
Primary Completion
2024-03-01
Completion
2024-03-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03380351 on ClinicalTrials.gov